Novartis Just Dropped $12 Billion on a Biotech Firm — This Could Change Medicine Forever
Novartis Makes a Jaw-Dropping $12 Billion Move Swiss pharmaceutical giant Novartis shocked the biotech world by agreeing to acquire U.S.-based
Adding {{itemName}} to cart
Added {{itemName}} to cart
